Panagora Asset Management’s Evolent Health EVH Stock Holding History

Panagora Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40,483	Closed	-$1.14M	–	1466
2022 Q4	$1.14M	Sell	40,483 -100,412	-71%	-$2.88M	0.01%	838
2022 Q3	$5.06M	Buy	140,895 +123,175	+695%	+$4.34M	0.04%	354
2022 Q2	$544K	Buy	+17,720	New	+$516K	﹤0.01%	1135
2017 Q4	–	Sell	-76,041	Closed	-$1.35M	–	2313
2017 Q3	$1.35M	Sell	76,041 -24,728	-25%	-$509K	0.01%	1007
2017 Q2	$2.55M	Sell	100,769 -18,098	-15%	-$435K	0.01%	779
2017 Q1	$2.65M	Buy	118,867 +15,150	+15%	+$291K	0.01%	779
2016 Q4	$1.53M	Sell	103,717 -81,282	-44%	-$1.6M	0.01%	1013
2016 Q3	$4.55M	Buy	+184,999	New	+$4.32M	0.02%	574
2015 Q4	–	Sell	-94,354	Closed	-$1.51M	–	2318
2015 Q3	$1.51M	Buy	+94,354	New	+$1.84M	0.01%	858

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Panagora Asset Management's EVH Position: Q1 2023 in Review

Panagora Asset Management sold out of Evolent Health (EVH) in Q1 2023, closing a stake of 40,483 shares — an estimated $1.14M sold.

Panagora Asset Management first reported a position in EVH in Q3 2015 and held it in 9 quarters. The position peaked at $5.06M in Q3 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q1 2023.

Panagora Asset Management reported no remaining Evolent Health position as of Q1 2023 after selling out during the quarter.
Panagora Asset Management sold 40,483 Evolent Health shares in Q1 2023, an estimated $1.14M.
Panagora Asset Management first reported a position in Evolent Health in Q3 2015 and held it in 9 quarters.
Panagora Asset Management's Evolent Health position peaked at $5.06M in Q3 2022.
240 funds tracked by Wall St. Rank held Evolent Health as of Q1 2023.

Based on Panagora Asset Management's 13F filing for Q1 2023, filed 12 May 2023.